Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 3/2005

01-03-2005 | Original Article

Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy

Authors: Miguel Hernandez-Pampaloni, Jeroen J. Bax, Koichi Morita, David P. Dutka, Paolo G. Camici

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2005

Login to get access

Abstract

Purpose

Different criteria to identify residual viability in chronically dysfunctioning myocardium in patients with coronary artery disease (CAD) can be derived by the combined assessment of myocardial blood flow (MBF) and glucose utilisation (MRG) using positron emission tomography (PET). The aim of this study was to evaluate, in a large number of patients, the prevalence of these different patterns by purely quantitative means.

Methods

One hundred and sixteen consecutive patients with ischaemic cardiomyopathy (LVEF ≤40%) underwent resting 2D echocardiography to assess regional contractile function (16-segment model). PET with 15O-labelled water (H215O) and 18F-fluorodeoxyglucose (FDG) was used to quantify MBF and MRG during hyperinsulinaemic euglycaemic clamp. Dysfunctional segments with normal MBF (≥0.6 ml min−1 g−1) were classified as stunned, and segments with reduced MBF (<0.6 ml min−1 g−1) as hibernating if MRG was ≥0.25 μmol min−1 g−1. Segments with reduced MBF and MRG <0.20 μmol min−1 g−1 were classified as transmural scars and segments with reduced MBF and MRG between 0.20 and 0.25 μmol min−1 g−1 as non-transmural scars.

Results

Eight hundred and thirty-four (46%) segments were dysfunctional. Of these, 601 (72%) were chronically stunned, with 368 (61%) having normal MRG (0.47±0.20 μmol min−1 g−1) and 233 (39%) reduced MRG (0.16±0.05 μmol min−1 g−1). Seventy-four (9%) segments with reduced MBF had preserved MRG (0.40±0.18 μmol min−1 g−1) and were classified as hibernating myocardium. In addition, 15% of segments were classified as transmural and 4% as non-transmural scar. The mean MBF was highest in stunned myocardium (0.95±0.32 ml min−1 g−1), intermediate in hibernating myocardium and non-transmural scars (0.47±0.09 ml min−1 g−1 and 0.48±0.08 ml min−1 g−1, respectively), and lowest in transmural scars (0.40±0.14 ml min−1 g−1, P<0.01). MRG was comparable in hibernating and stunned myocardium with preserved MRG (0.40±0.19 μmol min−1 g−1 vs 0.46±0.20 μmol min−1 g−1, NS), and lowest in stunned myocardium with reduced MRG and transmural scars.

Conclusion

Chronic stunning is more prevalent than expected. The degree of MRG reduction in stunned myocardium may disclose segments at higher risk of permanent damage.
Literature
1.
go back to reference Dilsizian V, Bonow RO. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1–20.PubMed Dilsizian V, Bonow RO. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1–20.PubMed
2.
go back to reference Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451–60.CrossRefPubMed Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451–60.CrossRefPubMed
3.
go back to reference Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997–1004.PubMed Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997–1004.PubMed
4.
go back to reference Pagano D, Townend JN, Littler WA, Horton R, Camici PG, Bonser RS. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791–9.PubMed Pagano D, Townend JN, Littler WA, Horton R, Camici PG, Bonser RS. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791–9.PubMed
5.
go back to reference Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693–700.CrossRefPubMed Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693–700.CrossRefPubMed
6.
go back to reference Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahintoola SH. Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:146–86. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahintoola SH. Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:146–86.
7.
go back to reference Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, Summers RM, Quyyumi AA, Dilsizian V. 13N-ammonia myocardial blood flow and uptake. Relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol 1999;33:678–86.CrossRefPubMed Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, Summers RM, Quyyumi AA, Dilsizian V. 13N-ammonia myocardial blood flow and uptake. Relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol 1999;33:678–86.CrossRefPubMed
8.
go back to reference Fallavolita JA, Canty JM. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation 1999;99:2798–805.PubMed Fallavolita JA, Canty JM. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation 1999;99:2798–805.PubMed
9.
go back to reference Gerber BL, Vanoverschelde JLJ, Bol A, Michel C, Labar D, Wijns W, Melin JA. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651–9.PubMed Gerber BL, Vanoverschelde JLJ, Bol A, Michel C, Labar D, Wijns W, Melin JA. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651–9.PubMed
10.
go back to reference Marinho NVS, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737–44.PubMed Marinho NVS, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737–44.PubMed
11.
go back to reference Maki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki LM, Ruotsalainen U, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658–66.PubMed Maki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki LM, Ruotsalainen U, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658–66.PubMed
12.
go back to reference Hashimoto K, Nishimura T, Ishikawa M, Koga K, Mori T, Matsuda S, et al. Enhancement of glucose uptake in stunned myocardium: role of glucose transporter. Am J Physiol Heart Circ Physiol 1997;272:H1122–30. Hashimoto K, Nishimura T, Ishikawa M, Koga K, Mori T, Matsuda S, et al. Enhancement of glucose uptake in stunned myocardium: role of glucose transporter. Am J Physiol Heart Circ Physiol 1997;272:H1122–30.
13.
go back to reference Fallavolita JA, Trojan C, Canty JM. Transmural distribution of FDG uptake in stunned myocardium. Am J Physiol Heart Circ Physiol 2000;279:H102–9. Fallavolita JA, Trojan C, Canty JM. Transmural distribution of FDG uptake in stunned myocardium. Am J Physiol Heart Circ Physiol 2000;279:H102–9.
14.
go back to reference Perrone-Filardi P, Bacharach SL, Dilsizian V, Marin-Neto JA, Maurea S, Arrighi JA, Bonow RO. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:608–16.PubMed Perrone-Filardi P, Bacharach SL, Dilsizian V, Marin-Neto JA, Maurea S, Arrighi JA, Bonow RO. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:608–16.PubMed
15.
go back to reference Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Takeuchi K, Yoshikawa J, Ochi H. A reverse flow–metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999;40:1492–8.PubMed Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Takeuchi K, Yoshikawa J, Ochi H. A reverse flow–metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999;40:1492–8.PubMed
16.
go back to reference Mesotten L, Maes A, Herregods MC, Desmet W, Nuyts J, Van de Werf F, Mortelmans L. PET “reversed mismatch pattern” early after acute myocardial infarction: follow-up of flow, metabolism and function. Eur J Nucl Med 2001;28:466–71.CrossRefPubMed Mesotten L, Maes A, Herregods MC, Desmet W, Nuyts J, Van de Werf F, Mortelmans L. PET “reversed mismatch pattern” early after acute myocardial infarction: follow-up of flow, metabolism and function. Eur J Nucl Med 2001;28:466–71.CrossRefPubMed
17.
go back to reference Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography; American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.PubMed Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography; American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.PubMed
18.
go back to reference Spinks TJ, Jones T, Gilardi MC, Heather JD. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci 1998;35:721–25.CrossRef Spinks TJ, Jones T, Gilardi MC, Heather JD. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci 1998;35:721–25.CrossRef
19.
go back to reference De Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738–42.PubMed De Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738–42.PubMed
20.
go back to reference Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H, Rechavia E, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labelled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875–85.PubMed Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H, Rechavia E, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labelled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875–85.PubMed
21.
go back to reference Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA. Measurement of myocardial blood flow with oxygen-15-labelled water: comparison of different administration protocols. Eur J Nucl Med 1998;25:751–9.CrossRefPubMed Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA. Measurement of myocardial blood flow with oxygen-15-labelled water: comparison of different administration protocols. Eur J Nucl Med 1998;25:751–9.CrossRefPubMed
22.
go back to reference Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1–7.PubMed Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1–7.PubMed
23.
go back to reference Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151–61.CrossRefPubMed Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151–61.CrossRefPubMed
24.
go back to reference Fath-Ordoubadi F, Beatt KJ, Spyrou N, Camici PG. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart 1999;82:210–6.PubMed Fath-Ordoubadi F, Beatt KJ, Spyrou N, Camici PG. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart 1999;82:210–6.PubMed
25.
go back to reference Chareonthaitawee P, Schaefers K, Baker CSR, Turkheimer F, Stegger L, Banner NR, et al. Infarct size assessed by positron emission tomography and [18F]2-fluoro-2-deoxy-d-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging 2002;29:203–15.CrossRefPubMed Chareonthaitawee P, Schaefers K, Baker CSR, Turkheimer F, Stegger L, Banner NR, et al. Infarct size assessed by positron emission tomography and [18F]2-fluoro-2-deoxy-d-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging 2002;29:203–15.CrossRefPubMed
26.
go back to reference Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884–8.PubMed Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884–8.PubMed
27.
go back to reference Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920–31.PubMed Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920–31.PubMed
28.
go back to reference Knuuti J, Schelbert HR, Bax J. The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2002;29:1257–66.CrossRefPubMed Knuuti J, Schelbert HR, Bax J. The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2002;29:1257–66.CrossRefPubMed
29.
go back to reference Schelbert HR. Measurements of myocardial metabolism in patients with ischemic heart disease. Am J Cardiol 1998;82:61K–7K.CrossRefPubMed Schelbert HR. Measurements of myocardial metabolism in patients with ischemic heart disease. Am J Cardiol 1998;82:61K–7K.CrossRefPubMed
30.
go back to reference Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994;90:735–45.PubMed Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994;90:735–45.PubMed
31.
go back to reference Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000;83:456–61.CrossRefPubMed Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000;83:456–61.CrossRefPubMed
32.
go back to reference Nitzsche EU, Choi Y, Hoh CK, Czernin J, Schelbert HR. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation 1996;93(11):2000–6.PubMed Nitzsche EU, Choi Y, Hoh CK, Czernin J, Schelbert HR. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation 1996;93(11):2000–6.PubMed
33.
go back to reference Camici PG, Spinks TJ. Advance imaging-PET. In: de Bono DSE editor. Challenges in acute coronary syndromes. Oxford:Blackwell; 1998. pp 148–72. Camici PG, Spinks TJ. Advance imaging-PET. In: de Bono DSE editor. Challenges in acute coronary syndromes. Oxford:Blackwell; 1998. pp 148–72.
34.
go back to reference Lammertsma AA, De Silva R, Araujo LI, Jones T. Measurement of regional myocardial blood flow using C15O2 and positron emission tomography: comparison of tracer models. Clin Phys Physiol Meas 1992;13(1):1–20. Lammertsma AA, De Silva R, Araujo LI, Jones T. Measurement of regional myocardial blood flow using C15O2 and positron emission tomography: comparison of tracer models. Clin Phys Physiol Meas 1992;13(1):1–20.
35.
go back to reference Camici PG, Rimoldi O. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 2003;57(2):302–11.CrossRefPubMed Camici PG, Rimoldi O. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 2003;57(2):302–11.CrossRefPubMed
36.
go back to reference McFalls EO, Baldwin D, Palmer B, Marx D, Jaimes D, Ward HB. Regional glucose uptake within hypoperfused swine myocardium as measured by positron emission tomography. Am J Physiol Heart Circ Physiol 1997;272:H343–9. McFalls EO, Baldwin D, Palmer B, Marx D, Jaimes D, Ward HB. Regional glucose uptake within hypoperfused swine myocardium as measured by positron emission tomography. Am J Physiol Heart Circ Physiol 1997;272:H343–9.
37.
go back to reference Mills I, Fallon JT, Wrenn D, Sasken H, Gray W, Bier J, et al. Adaptative responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol Heart Circ Physiol 1994;266:H447–57. Mills I, Fallon JT, Wrenn D, Sasken H, Gray W, Bier J, et al. Adaptative responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol Heart Circ Physiol 1994;266:H447–57.
38.
go back to reference Fallavolita JA, Malm BJ, Canty JN Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003;92:48–55.CrossRefPubMed Fallavolita JA, Malm BJ, Canty JN Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003;92:48–55.CrossRefPubMed
39.
go back to reference Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996;98(9):2094–9.PubMed Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996;98(9):2094–9.PubMed
40.
go back to reference Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002;51(10):3020–4.PubMed Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002;51(10):3020–4.PubMed
Metadata
Title
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy
Authors
Miguel Hernandez-Pampaloni
Jeroen J. Bax
Koichi Morita
David P. Dutka
Paolo G. Camici
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2005
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1682-y

Other articles of this Issue 3/2005

European Journal of Nuclear Medicine and Molecular Imaging 3/2005 Go to the issue

Announcements

March 2005

News & Views

March 2005